Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

The conclusion is that understanding how feathers and hairs pattern can help in developing hair regeneration treatments.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Androgens significantly affect female hair loss, and hormonal treatments may help.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Obese women with PCOS are more likely to have fatty liver disease.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Hormonal therapies are safe and effective for treating adult women's acne.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Finasteride improves acne and hair loss in women with normal testosterone.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Hair growth is influenced by various body and external factors, and neighboring hairs communicate to synchronize regeneration.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.